Financial News
Articles published by Renovaro Inc
Renovaro Regains Compliance with NASDAQ Listing Requirement
December 20, 2024
From Renovaro Inc
Via GlobeNewswire
Tickers
RENB
Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection
December 20, 2024
From Renovaro Inc
Via GlobeNewswire
Tickers
RENB
Renovaro Issues Shareholder Letter and Provides Corporate Update
November 04, 2024
From Renovaro Inc
Via GlobeNewswire
Tickers
RENB
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
October 17, 2024
From Renovaro Inc
Via GlobeNewswire
Tickers
RENB
Renovaro Announces Strategic Restructuring and Leadership Transition
October 16, 2024
From Renovaro Inc
Via GlobeNewswire
Tickers
RENB
RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress
September 13, 2024
From Renovaro Inc
Via GlobeNewswire
Tickers
RENB
RenovaroCube Announces Strategic Offering of Up to 20% Ownership
September 11, 2024
From Renovaro Inc
Via GlobeNewswire
Tickers
RENB
Renovaro, Inc. Announces $10 million in Equity Committed
June 14, 2024
From Renovaro Inc
Via GlobeNewswire
Tickers
RENB
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
April 30, 2024
From Renovaro Inc
Via GlobeNewswire
Tickers
RENB
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
April 24, 2024
From Renovaro Inc
Via GlobeNewswire
Tickers
RENB
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.